2-(2,3-Dimethyl-phenoxy)-propionic acid, 90.0%, 5g

Tert-butyl (S)-2-cyano-4,4-difluoropyrrolidine-1-carboxylate, 98%, 500mg

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 98%, 250mg

Tetrakis(dimethylamino)diboron>95.0%(N)1g

(3,3-difluoropiperidin-4-yl)methanol hydrochloride, 95.0%, 500mg

ethyl 3-[(2-methoxyethyl)amino]propanoate, 95.0%, 2g

Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-, 95%, 25g

methyl 5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylate, 95.0%, 5g

5-METHYL-2-(METHYLTHIO)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE, 95.0%, 100mg

(2E)-1-(3-chlorophenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one, 95.0%, 10g

Butyl 2-cyanoacrylate, 95.0%, 1g

(5-METHOXYPYRIMIDIN-2-YL)METHANOL, 95.0%, 250mg

5-((3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)-5H-dibenzo[b,f]azepine, 97%, 250mg